Home
Conditions
HIV-1-infection

Clinical trial condition

HIV-1-infection

Explore clinical trials studying HIV-1-infection. Study availability and eligibility vary by location and protocol.

230 public trials 34 recruiting studies

Refine in advanced search Browse all conditions

HIV-1-infection trial results

Completed

Second-line Switch to Dolutegravir Study

NCT04229290

Conditions: HIV-1-infection
Locations: Kiambu Level 5 Hospital Kiambu, Kenya

Jaramogi Oginga Odinga Teaching and Referral Hospital Kisumu, Kenya

Kenyatta National Hospital Nairobi, Kenya

Thika Level 5 Hospital Thika, Kenya

View Trial Details

Completed

Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs

NCT03709355

Conditions: HIV-1-infection
Locations: Central Clinical City Hospital Reutov, Moscow Oblast, Russia

View Trial Details

Completed

Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed

NCT03110380

Conditions: HIV-1-infection
Locations: Spectrum Medical Group Phoenix, Arizona, United States

Ruane Clinical Research Group Inc. Los Angeles, California, United States

Mills Clinical Research Los Angeles, California, United States

Highland Hospital - Alameda Health System Oakland, California, United States

View all 94 locations

View Trial Details

Completed

D²EFT Graphical Informed Consent

NCT04668443

Conditions: HIV-1-infection
Locations: Institute of Human Virology Nigeria (IHVN) Abuja, Nigeria

View Trial Details

Completed

Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs

NCT03706898

Conditions: HIV-1-infection, Hepatic Impairment
Locations: Regional State Budgetary Healthcare Institution "Smolensk Regional Clinical Hospital" Smolensk, Russia

View Trial Details

Completed

Open Labelled, Randomized Study to Evaluate the Efficacy, Safety and Dose Selection of VM-1500A-LAI Drug in HIV-infected Patients Transferred From Previous Stable Therapy (NNRTI + 2NRTI), Including ELPIDA®

NCT05163535

Conditions: HIV-1-infection
Locations: Federal State Budgetary Institution of the Central Research Institute of Epidemiology of Rospotrebnadzor Moscow, Russia

St. Petersburg State Medical Institution " Center for AIDS and Infectious Diseases" Saint Petersburg, Russia

View Trial Details

Completed

Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women

NCT03837015

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bacterial Vaginoses, +10 more
Locations: Women's Health in Women's Hands Toronto, Ontario, Canada

View Trial Details

Completed

Study to Evaluate Safety, Tolerability and Pharmacokinetics of VM-1500A-LAI Single and Multiple Ascending Doses in Healthy Subjects

NCT03706911

Conditions: HIV-1-infection
Locations: Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) Moscow, Russia

View Trial Details

Completed

An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

NCT05148754

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations: State Budgetary Institution Healthcare of the City of Moscow " V. P. Demikhov City Clinical Hospital of the Department of Healthcare of the City of Moscow" Moscow, Russia

View Trial Details

Completed

A Pilot Trial of Perinatal Depression Treatment in HIV Infected Women

NCT04094870

Conditions: HIV-1-infection, Perinatal Depression
Locations: Kamwala District Health Centre Lusaka, Zambia

University Teaching Hospital Lusaka, Zambia

View Trial Details

HIV-1-infection

HIV-1-infection trial results

Related conditions